Executive Director, MA&EG Asset Lead

argenx SE; United States; À distance; USD 326 000 - 448 000; Plein temps

Avantages offerts par ce poste

Retirement savings plans

Health benefits

Other benefits

Résumé du poste

argenx SE in the United States (remote acceptable) seeks a Medical Affairs and Evidence Generation Asset Lead for FB-102 to guide indication strategy, target product profile development, clinical plans, and lifecycle management with global teams across science, clinical development, medical affairs, evidence generation, and commercial.

This strategic leader sits on the argenx Asset Strategy Team, represents MA&EG activities, and helps build a best-in-class MA&EG organization while ensuring high

Qualifications

• Advanced degree in a scientific specialty (MD, PhD, PharmD or equivalent) required.
• 15 years gastroenterology clinical practice experience, gastroenterology research experience, and/or specific gastroenterology biopharmaceutical industry experience.
• Min 5 years medical affairs industry strongly preferred.
• Experience designing, conducting, and interpreting clinical trials.

Responsabilités

• Serve as the MA&EG lead on the FB-102 Asset Strategy Team with input from regional and country MA&EG teams to guide development and lifecycle management.
• Develop and execute Integrated Evidence Generation Plans throughout the product lifecycle.
• Lead MA&EG strategies via scientific communications, advisory boards, medical information, congress activities, and data generation.
• Hire and manage indication leads as the molecule progresses in development.

Connaissances

Medical affairs leadership

Strategic planning

Clinical development

Stakeholder engagement

Communication

People management

Formation

MD/PhD/PharmD or equivalent

15 years gastroenterology clinical practice or industry experience

Min 5 years medical affairs experience

Description du poste

argenx SE in the United States (remote acceptable) seeks a Medical Affairs and Evidence Generation Asset Lead for FB-102 to guide indication strategy, target product profile development, clinical plans, and lifecycle management with global teams across science, clinical development, medical affairs, evidence generation, and commercial.

This strategic leader sits on the argenx Asset Strategy Team, represents MA&EG activities, and helps build a best-in-class MA&EG organization while ensuring high